What happened
BioInfra filed provisional (unaudited) separate results for Q2 2026: revenue of US$5.88M (+42.5% year on year), operating profit of US$154K (from a loss a year earlier) and net income of US$103K (from a loss a year earlier).
These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.
| Revenue | US$5.88M |
|---|---|
| Revenue vs a year earlier | +42.5% |
| Operating profit | US$154K |
| Net income | US$103K |
| Period | Q2 2026 (separate) |
| Filed | 2026-07-24, Operating results (preliminary) (fair disclosure) |
| Source | DART rcept 20260724900802 → open original filing |
Source: DART. Information only, not investment advice.